JPWO2022045052A1 - - Google Patents
Info
- Publication number
- JPWO2022045052A1 JPWO2022045052A1 JP2022544576A JP2022544576A JPWO2022045052A1 JP WO2022045052 A1 JPWO2022045052 A1 JP WO2022045052A1 JP 2022544576 A JP2022544576 A JP 2022544576A JP 2022544576 A JP2022544576 A JP 2022544576A JP WO2022045052 A1 JPWO2022045052 A1 JP WO2022045052A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
- C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020143639 | 2020-08-27 | ||
| JP2020143639 | 2020-08-27 | ||
| PCT/JP2021/030755 WO2022045052A1 (ja) | 2020-08-27 | 2021-08-23 | トリスルフィド化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022045052A1 true JPWO2022045052A1 (https=) | 2022-03-03 |
| JP7650279B2 JP7650279B2 (ja) | 2025-03-24 |
Family
ID=80353266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544576A Active JP7650279B2 (ja) | 2020-08-27 | 2021-08-23 | トリスルフィド化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12534432B2 (https=) |
| EP (1) | EP4194437B1 (https=) |
| JP (1) | JP7650279B2 (https=) |
| CN (1) | CN115943140B (https=) |
| ES (1) | ES3054285T3 (https=) |
| PL (1) | PL4194437T3 (https=) |
| WO (1) | WO2022045052A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7842033B2 (ja) | 2020-05-12 | 2026-04-07 | ザ ジェネラル ホスピタル コーポレイション | 神経保護におけるグルタチオントリスルフィド（ｇｓｓｓｇ） |
| EP4342464A4 (en) | 2021-07-08 | 2025-06-04 | Kyowa Pharma Chemical Co., Ltd. | PROPHYLACTIC OR THERAPEUTIC MEDICINE FOR PARKINSON'S DISEASE |
| EP4603087A1 (en) | 2022-11-21 | 2025-08-20 | Kyowa Hakko Bio Co., Ltd. | Prophylactic or therapeutic agent for acute kidney injury induced by anticancer agent |
| CN120344503A (zh) | 2022-12-27 | 2025-07-18 | 协和医药化工股份有限公司 | 三硫化物化合物 |
| WO2025070464A1 (ja) | 2023-09-28 | 2025-04-03 | 協和ファーマケミカル株式会社 | トリスルフィド化合物を含有する医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS532931B2 (https=) * | 1973-12-05 | 1978-02-01 | ||
| JPS5819673B2 (ja) * | 1976-08-26 | 1983-04-19 | 相互薬工業株式会社 | パンテチンの製造方法 |
| JP2928414B2 (ja) | 1991-09-20 | 1999-08-03 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| SE9402253D0 (sv) * | 1994-06-27 | 1994-06-27 | Pharmacia Ab | Process |
| CN107652264A (zh) | 2017-09-25 | 2018-02-02 | 苏州华诺医药有限公司 | 硫辛酸杂质a的制备方法 |
| JP2022074166A (ja) * | 2019-01-30 | 2022-05-18 | 協和発酵バイオ株式会社 | ポリスルフィド化合物を含有する組成物 |
| JP2022166333A (ja) * | 2019-09-18 | 2022-11-02 | 国立大学法人 熊本大学 | 活性イオウ分子種生体内濃度上昇剤 |
-
2021
- 2021-08-23 JP JP2022544576A patent/JP7650279B2/ja active Active
- 2021-08-23 ES ES21861478T patent/ES3054285T3/es active Active
- 2021-08-23 US US18/042,705 patent/US12534432B2/en active Active
- 2021-08-23 EP EP21861478.2A patent/EP4194437B1/en active Active
- 2021-08-23 PL PL21861478.2T patent/PL4194437T3/pl unknown
- 2021-08-23 WO PCT/JP2021/030755 patent/WO2022045052A1/ja not_active Ceased
- 2021-08-23 CN CN202180050867.6A patent/CN115943140B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7650279B2 (ja) | 2025-03-24 |
| WO2022045052A1 (ja) | 2022-03-03 |
| US20230357141A1 (en) | 2023-11-09 |
| ES3054285T3 (en) | 2026-02-02 |
| CN115943140A (zh) | 2023-04-07 |
| US12534432B2 (en) | 2026-01-27 |
| PL4194437T3 (pl) | 2026-02-02 |
| EP4194437B1 (en) | 2025-11-12 |
| EP4194437A1 (en) | 2023-06-14 |
| CN115943140B (zh) | 2024-10-01 |
| EP4194437A4 (en) | 2024-10-02 |
| EP4194437C0 (en) | 2025-11-12 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240816 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250121 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250304 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250311 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7650279 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |